| Bioactivity | Dimiracetam is an orally active compound, with anti-neuropathic activity. Dimiracetam inhibits hypersensitivity and neurological alterations, and inhibits Sorafenib (HY-10201)-induced neuropathy in cold stimulation rat models[1]. | ||||||||||||
| Name | Dimiracetam | ||||||||||||
| CAS | 126100-97-8 | ||||||||||||
| Formula | C6H8N2O2 | ||||||||||||
| Molar Mass | 140.14 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Di Cesare Mannelli L, et al. A model of neuropathic pain induced by sorafenib in the rat: Effect of dimiracetam. Neurotoxicology. 2015 Sep;50:101-7. [2]. Di Cesare Mannelli L, et al. A rat model of FOLFOX-induced neuropathy: effects of oral dimiracetam in comparison with duloxetine and pregabalin. Cancer Chemother Pharmacol. 2017 Dec;80(6):1091-1103. |
Dimiracetam
CAS: 126100-97-8 F: C6H8N2O2 W: 140.14
Dimiracetam is an orally active compound, with anti-neuropathic activity. Dimiracetam inhibits hypersensitivity and neur
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.